ICON (ICLR) Stock Price

ICON Price

NASDAQ·CLOSED
166.18USD-3.82 (-2.27 %)
Market closed

Over the last 19 years ICON grew revenue by 18.5% annually, reaching 8.28 B USD. Earnings per share have grown at 21.4% per year over the last 19 years. For ICON, the net margin of 9.6% is down versus 11.9% a few years ago. The consensus 12-month price target for ICON is 132.60 USD, about 20.2% below where the stock trades today. Of 24 analysts, 13 rate the stock a buy — an overall Buy consensus. The stock trades about 108% above its 52-week low.

ICON stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of ICON over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how ICON stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing ICON's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

ICON Stock Price History
DateICON Price
7/20/2026166.18 USD
7/17/2026170.00 USD
7/16/2026170.00 USD
7/15/2026172.08 USD
7/14/2026167.97 USD
7/13/2026167.28 USD
7/10/2026167.72 USD
7/9/2026168.77 USD
7/8/2026165.40 USD
7/7/2026168.72 USD
7/6/2026169.54 USD
7/2/2026173.06 USD
7/1/2026175.05 USD
6/30/2026173.71 USD
6/29/2026170.18 USD
6/26/2026169.86 USD
6/25/2026160.96 USD
6/24/2026158.17 USD
6/23/2026142.67 USD
6/22/2026140.73 USD
6/18/2026146.00 USD
6/17/2026143.27 USD
6/16/2026143.54 USD
6/15/2026147.72 USD
6/12/2026146.18 USD
6/11/2026149.92 USD
6/10/2026144.59 USD
6/5/2026149.45 USD
6/4/2026152.80 USD
6/3/2026143.90 USD
6/2/2026137.54 USD
6/1/2026138.03 USD
5/29/2026136.07 USD
5/28/2026136.80 USD
5/27/2026118.45 USD
5/26/2026113.85 USD
5/22/2026116.78 USD
5/21/2026116.57 USD
5/20/2026115.09 USD
5/19/2026113.55 USD
5/14/2026117.09 USD
5/12/2026121.94 USD
5/11/2026118.96 USD
5/8/2026124.49 USD
5/7/2026125.00 USD
5/6/2026124.13 USD
5/5/2026121.32 USD
5/4/2026111.97 USD
5/1/2026112.85 USD
4/30/2026118.33 USD
4/29/2026116.17 USD
4/28/2026102.49 USD
4/27/2026103.21 USD
4/24/2026102.17 USD
4/23/2026106.34 USD
4/22/2026115.43 USD
4/21/2026115.18 USD
4/20/2026117.12 USD
4/17/2026119.68 USD
4/16/2026115.58 USD
4/15/2026116.50 USD
4/14/2026113.06 USD
4/13/2026110.37 USD
4/10/2026106.81 USD
4/9/2026106.70 USD
4/8/2026106.54 USD
4/7/2026107.16 USD
4/6/2026109.62 USD
4/2/2026114.19 USD
4/1/2026111.42 USD
3/31/2026110.66 USD
3/30/2026105.10 USD
3/27/2026102.08 USD
3/26/2026103.08 USD
3/25/202699.99 USD
3/24/2026101.28 USD
3/23/2026100.35 USD
3/20/202699.70 USD
3/19/202698.05 USD
3/18/202697.14 USD
3/17/2026100.49 USD
3/16/202697.61 USD
3/13/202698.33 USD
3/12/202697.45 USD
3/11/2026105.38 USD
3/10/2026106.62 USD
3/9/2026110.03 USD
3/6/2026107.20 USD
3/5/2026110.60 USD
3/4/2026110.20 USD
3/3/2026108.70 USD
3/2/2026108.27 USD
2/27/2026108.14 USD
2/26/2026106.13 USD
2/25/2026101.00 USD
2/24/2026104.09 USD
2/23/2026104.66 USD
2/20/202699.70 USD
2/19/202698.41 USD
2/18/202696.50 USD
2/17/202688.62 USD
2/13/202693.00 USD
2/12/202680.08 USD
2/11/2026133.14 USD
2/10/2026144.55 USD
2/9/2026154.57 USD
2/6/2026150.59 USD
2/5/2026145.39 USD
2/4/2026163.11 USD
2/3/2026167.91 USD
2/2/2026178.59 USD
1/30/2026180.25 USD
1/29/2026185.89 USD
1/28/2026186.32 USD
1/27/2026187.97 USD
1/26/2026187.42 USD
1/23/2026186.70 USD
1/22/2026186.74 USD
1/21/2026184.87 USD
1/20/2026176.57 USD
1/16/2026182.61 USD
1/15/2026182.56 USD
1/14/2026184.77 USD
1/13/2026183.29 USD
1/12/2026180.15 USD
1/9/2026181.38 USD
1/8/2026188.22 USD
1/7/2026202.92 USD
1/6/2026201.48 USD
1/5/2026197.58 USD
1/2/2026188.67 USD
12/31/2025182.22 USD
12/30/2025183.00 USD
12/29/2025182.36 USD
12/26/2025182.84 USD
12/24/2025183.68 USD
12/23/2025183.07 USD
12/22/2025179.14 USD
12/19/2025173.77 USD
12/18/2025178.70 USD
12/17/2025179.34 USD
12/16/2025182.45 USD
12/15/2025184.37 USD
12/12/2025186.58 USD
12/11/2025189.93 USD
12/10/2025185.86 USD
12/9/2025181.29 USD
12/8/2025182.10 USD
12/5/2025185.87 USD
12/4/2025185.77 USD
12/3/2025187.78 USD
12/2/2025183.14 USD
12/1/2025179.71 USD
11/28/2025185.00 USD
11/26/2025183.65 USD
11/25/2025174.53 USD
11/24/2025164.55 USD
11/21/2025164.56 USD
11/20/2025158.12 USD
11/19/2025158.81 USD
11/18/2025161.02 USD
11/17/2025156.49 USD
11/14/2025162.18 USD
11/13/2025163.45 USD
11/12/2025163.42 USD
11/11/2025163.42 USD
11/10/2025157.68 USD
11/7/2025159.14 USD
11/6/2025160.00 USD
11/5/2025163.70 USD
11/4/2025162.96 USD
11/3/2025168.79 USD
10/31/2025171.82 USD
10/30/2025165.33 USD
10/29/2025165.95 USD
10/28/2025177.73 USD
10/27/2025182.03 USD
10/24/2025178.11 USD
10/23/2025180.00 USD
10/22/2025192.60 USD
10/21/2025193.26 USD
10/20/2025188.45 USD
10/17/2025185.06 USD
10/16/2025188.46 USD
10/15/2025187.85 USD
10/14/2025185.91 USD
10/13/2025186.05 USD
10/10/2025183.49 USD
10/9/2025187.71 USD
10/8/2025186.48 USD
10/7/2025186.65 USD
10/6/2025190.43 USD
10/3/2025193.89 USD
10/2/2025192.96 USD
10/1/2025192.31 USD
9/30/2025175.00 USD
9/29/2025163.44 USD
9/26/2025163.79 USD
9/25/2025162.53 USD
9/24/2025167.49 USD
9/23/2025170.38 USD
9/22/2025170.80 USD
9/19/2025174.00 USD
9/18/2025179.43 USD
9/17/2025175.21 USD
9/16/2025173.13 USD
9/15/2025170.46 USD
9/12/2025175.00 USD
9/11/2025175.11 USD
9/10/2025165.44 USD
9/9/2025168.94 USD
9/8/2025177.81 USD
9/5/2025174.88 USD
9/4/2025176.36 USD
9/3/2025180.01 USD
9/2/2025177.84 USD
8/29/2025177.94 USD
8/28/2025175.05 USD
8/27/2025174.00 USD
8/26/2025171.76 USD
8/25/2025171.75 USD
8/22/2025175.83 USD
8/21/2025175.70 USD
8/20/2025180.25 USD
8/19/2025179.64 USD
8/18/2025178.56 USD
8/15/2025175.84 USD
8/14/2025175.36 USD
8/13/2025176.29 USD
8/12/2025169.08 USD
8/11/2025159.71 USD
8/8/2025158.44 USD
8/7/2025157.85 USD
8/6/2025155.42 USD
8/5/2025165.98 USD
8/4/2025164.80 USD
8/1/2025166.44 USD
7/31/2025169.19 USD
7/30/2025181.50 USD
7/29/2025185.21 USD
7/28/2025189.66 USD
7/25/2025187.01 USD
7/24/2025195.01 USD
7/23/2025167.89 USD
7/22/2025161.50 USD
Access this data via the Eulerpool API
Get Free API Key

ICON Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2022
7.74 B USD
866.00 M USD
505.30 M USD
Jan 1, 2023
8.12 B USD
1.05 B USD
612.34 M USD
Jan 1, 2024
8.28 B USD
1.22 B USD
791.47 M USD
Jan 1, 2025 (e)
8.22 B USD
1.34 B USD
1.10 B USD
Jan 1, 2026 (e)
8.15 B USD
1.29 B USD
1.05 B USD
Jan 1, 2027 (e)
8.49 B USD
1.35 B USD
1.15 B USD
Jan 1, 2028 (e)
9.20 B USD
1.61 B USD
1.40 B USD
Jan 1, 2029 (e)
9.09 B USD
1.55 B USD
1.29 B USD

ICON Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 22, 2026, 9:40 AM
 
REVENUEB USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB USD
EBITB USD
EBIT MARGIN%
NET INCOMEB USD
NET INCOME GROWTH%
SHARESM
2016201720182019202020212022202320242025e2026e2027e2028e2029e2030e2031e
1.671.762.602.812.805.487.748.128.288.228.158.499.209.099.6410.66
5.785.5247.618.09-0.2995.9241.264.901.98-0.78-0.824.168.39-1.236.0510.63
42.3241.5829.9429.6329.2827.5528.6529.6629.5129.5129.5129.5129.5129.5129.5129.51
0.710.730.780.830.821.512.222.412.442.422.412.512.722.682.843.15
0.320.350.390.430.410.610.871.051.221.341.291.351.611.551.68–
19.1519.6814.8415.4414.6211.0811.1912.8714.7216.3515.7715.9017.5017.0917.42–
0.260.280.320.370.330.150.510.610.791.101.051.151.401.291.482.01
9.627.2514.5916.15-11.23-53.92230.0721.1929.2538.69-3.929.3021.79-7.9114.1636.47
56.4054.8054.8054.3053.3068.1082.5082.7283.0383.0383.0383.0383.0383.0383.0383.03
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales ICON generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue ICON retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare ICON's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares ICON has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against ICON's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

ICON stock margins

The ICON margin analysis displays the gross margin, EBIT margin, as well as the profit margin of ICON. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for ICON.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2020
29.31 %
14.64 %
11.88 %
Jan 1, 2021
27.56 %
11.09 %
2.80 %
Jan 1, 2022
28.66 %
11.19 %
6.53 %
Jan 1, 2023
29.65 %
12.88 %
7.54 %
Jan 1, 2024
29.51 %
14.73 %
9.56 %
Jan 1, 2025 (e)
29.51 %
16.35 %
13.36 %
Jan 1, 2026 (e)
29.51 %
15.77 %
12.94 %
Jan 1, 2027 (e)
29.51 %
15.90 %
13.58 %

ICON Stock Revenue, EBIT, Earnings per Share

The ICON earnings per share therefore indicates how much revenue ICON has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2020
52.48 USD
7.68 USD
6.23 USD
Jan 1, 2021
80.48 USD
8.93 USD
2.25 USD
Jan 1, 2022
93.84 USD
10.50 USD
6.12 USD
Jan 1, 2023
98.17 USD
12.64 USD
7.40 USD
Jan 1, 2024
99.74 USD
14.69 USD
9.53 USD
Jan 1, 2025 (e)
98.95 USD
16.17 USD
13.22 USD
Jan 1, 2026 (e)
98.14 USD
15.48 USD
12.70 USD
Jan 1, 2027 (e)
102.23 USD
16.26 USD
13.89 USD

ICON business model & stock analysis

ICON PLC is a global company specializing in clinical research and development of pharmaceuticals. The company was founded in 1990 and is headquartered in Dublin, Ireland. It was formed through the merger of several smaller companies. Today, ICON PLC is one of the world's leading companies in the field of clinical trials.

ICON SWOT Analysis

Strengths

ICON PLC has established a strong global presence in the pharmaceutical and biotechnology industry, gaining a reputation as a trusted partner in clinical research and development.

The company offers a wide range of services including clinical trial management, data management, laboratory services, and consulting, enabling clients to streamline their drug development processes.

ICON PLC has a strong focus on technological advancements, leveraging innovative tools and technologies to improve the efficiency and accuracy of clinical trials and data analysis.

Weaknesses

ICON PLC's revenue is heavily reliant on a few key clients, which poses a risk to the company's financial stability in case of potential loss or reduced business from these clients.

The company's service offerings are primarily focused on clinical research and development, leaving it susceptible to changes in the pharmaceutical industry and potential shifts in client demands.

Opportunities

With the increasing global healthcare expenditure and demand for innovative treatments, ICON PLC can capitalize on the growing market by expanding its services and targeting emerging markets.

Continuous advancements in technology, such as the use of artificial intelligence and big data analytics, present opportunities for ICON PLC to enhance its service offerings, improve operational efficiency, and deliver more accurate insights to its clients.

Threats

The pharmaceutical industry is subject to strict regulatory requirements that can impact the speed and cost of drug development. Non-compliance or changes in regulations pose threats to ICON PLC's operations and profitability.

The industry is highly competitive, with numerous players offering similar services. ICON PLC faces the risk of losing market share to competitors who may offer more cost-effective or innovative solutions.

ICON Segments

ICON Revenue by Region

  • 3 Years

  • Max

United States
Ireland
Rest of Europe
Other Countries
Details
Date
United States
Ireland
Rest of Europe
Other Countries
Jan 1, 2021
2.58 B USD
1.37 B USD
1.18 B USD
358.40 M USD
Jan 1, 2022
3.57 B USD
1.98 B USD
1.62 B USD
563.86 M USD
Jan 1, 2023
3.28 B USD
2.38 B USD
1.57 B USD
884.50 M USD
Jan 1, 2024
2.99 B USD
2.79 B USD
1.56 B USD
942.64 M USD

ICON Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

ICON historical P/E ratio, EBIT multiple, and P/S ratio

ICON annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

ICON shares outstanding

The number of shares of ICON was 83.03 M in 2025. This indicates how many shares ICON is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2020
53.30 M Stocks
Jan 1, 2021
68.10 M Stocks
Jan 1, 2022
82.50 M Stocks
Jan 1, 2023
82.72 M Stocks
Jan 1, 2024
83.03 M Stocks
Jan 1, 2025 (e)
83.03 M Stocks
Jan 1, 2026 (e)
83.03 M Stocks
Jan 1, 2027 (e)
83.03 M Stocks

ICON stock splits

In ICON's history, there have been no stock splits.

Current ICON forecasts and price targets in July 2026

Analyst Price Targets 2026
Δ MOM Price Target
11.86 %
Buy54.17 % (13)
Hold41.67 % (10)
Sell4.17 % (1)
12M Price Target
132.60
Last Price
166.18
Currency
USD
12M Return Potential
-20.21 %
LTM Return
0 %

ICON Earnings Estimates

DateEPS estimateRevenue EstimateQuarterly report
7/21/20262.60USD2.05 BUSD2026 Q2
6/6/20263.19USD2.02 BUSD2025 Q4
6/2/20262.59USD2.03 BUSD2026 Q1
5/26/20262.82USD1.98 BUSD2026 Q1
4/30/20263.28USD2.04 BUSD2025 Q4
4/29/20263.09USD2.01 BUSD2026 Q1
2/25/20263.30USD2.04 BUSD2025 Q4
11/2/20223.00USD1.96 BUSD2022 Q3
7/27/20222.85USD1.96 BUSD2022 Q2
4/27/20222.75USD1.92 BUSD2022 Q1
...

EESG©

Eulerpool ESG Scorecard© for the ICON stock

59/100
54
Environment
83
Social
40
Governance
E

Environment

20
Scope 1 - Direct Emissions2,503
Scope 2 - Indirect emissions from purchased energy13,663
Scope 3 - Indirect emissions within the value chain25,353
Total CO₂ emissions16,166
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees71.903
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

ICON shareholder structure

% Name
10.06993%
Artisan Partners Limited Partnership
Artisan Partners Limited Partnership
5.23982%
Wellington Management Company, LLP
Wellington Management Company, LLP
5.07592%
Orbis Investment Management Ltd.
Orbis Investment Management Ltd.
3.96626%
Invesco Advisers, Inc.
Invesco Advisers, Inc.
3.61490%
Principal Global Investors (Equity)
Principal Global Investors (Equity)
3.54778%
Ninety One UK Limited
Ninety One UK Limited
...

ICON Executives and Management Board

SC

Dr. Stephen Cutler

(64)

Non-Executive Director · since 2014

Compensation4.52 M USD
CM

Mr. Ciaran Murray

(62)

Non-Executive Independent Chairman of the Board · since 2005

Compensation658,000.00 USD
RM

Mr. Ronan Murphy

(67)

Lead Independent Director

Compensation387,000.00 USD
EM

Mr. Eugene Mccague

(66)

Independent Director

Compensation343,000.00 USD
JO

Ms. Julie O'Neill

(59)

Independent Director

Compensation336,000.00 USD

Frequently asked questions about ICON

The main competitors of ICON PLC in the market include other Contract Research Organizations (CROs) such as Covance Inc., QuintilesIMS Holdings Inc., and PAREXEL International Corporation. These companies provide similar services and solutions in the clinical research and development industry, offering competition to ICON PLC's global presence and expertise.

All fundamentals and in-depth analysis of ICON

Our stock analysis for ICON stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ICON. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

ICON Stock
ICON Revenue→
ICON Stock
ICON Net Income→
ICON Stock
ICON P/E→
ICON Stock
ICON P/S→
ICON Stock
ICON EBIT→
ICON Stock
ICON Dividend→
ICON Stock
ICON Directors Dealings→
ICON Stock
ICON Stocks→
ICON Stock
ICON Market capitalization→
ICON Stock
ICON Debt→
ICON Stock
ICON Liabilities→
ICON Stock
ICON Equity→
ICON Stock
ICON AAQS→
ICON Stock
ICON Employees→
ICON Stock
ICON ROE→
ICON Stock
ICON ROA→
ICON Stock
ICON ROCE→
ICON Stock
ICON News→
ICON Stock
ICON Analyst Price Targets→

Health Stocks

IconovoIcecure MedicaliCoreConnectIcares MedicusICU MedicalIbnsina Pharma Co SAEIDEAYA BiosciencesiBioIDEXX LaboratoriesI SensIDL Diagnostics AB (publ)Hyundai Pharmaceutical CoAll Stocks A–Z →